PLA2G7 and Alzheimer disease: For example, in adults with resolved AD, the presence of long-term immune-modifying alterations in melanocytes, and upregulation of possible anti-inflammatory markers such as PLA2G7 compared to healthy control skin, may provide the basis for developing prognostic disease parameters and biomarkers for therapy responses in AD [110].